跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,300 条关于
“Lucid Capital Markets”
全部
11,300
临床试验
4,808
药物
43
机构
189
资讯
6,260
10个月前
Coya Therapeutics Raises $23 Million to Advance ALS Treatment Development
去年
Actuate Therapeutics Raises $17.25 Million to Advance GSK-3β Inhibitor for Difficult-to-Treat Cancers
去年
I-Mab Raises $65 Million to Advance Givastomig Phase 2 Trial for Gastric Cancer
去年
Galera Therapeutics Completes Acquisition of Nova Pharmaceuticals
9个月前
XOMA Royalty Completes $2.035 Per Share Acquisition of Mural Oncology
去年
Sonnet BioTherapeutics Pivots to Cryptocurrency with $888 Million HYPE Token Treasury Strategy
去年
Faron Pharmaceuticals' Bexmarilimab Shows Promise in Myelodysplastic Syndrome Treatment
9个月前
DelphX Capital Markets Completes C$112,000 Private Placement to Support Structured Products Development
去年
Quantum BioPharma Advances Lucid-21-302 Clinical Trial for Multiple Sclerosis
去年
Phase 1 Trial of Lucid-MS Initiated to Protect Myelin Sheath in Multiple Sclerosis
第 1 页,共 626 页
上一页
下一页